Felvizumab Biosimilar - Research Grade

Human

RSVï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants and older adults, and its fusion machinery is a key antiviral target. This unconjugated, non-therapeutic analog of felvizumab is a research-grade anti-RSV recombinant monoclonal antibody offered for research use only (RUO). The ultra-pure, low-endotoxin formulation is produced to demanding in vivo standards and supplied in scalable milligram (mg) to gram (g) quantities for heavy-usage, high-throughput laboratories. It supports neutralization assays, in vitro screening, in vivo challenge models, and biologics characterization.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks